Literature DB >> 12668989

Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis.

Sherzad Balata1, Steven W M Olde Damink, Karen Ferguson, Ian Marshall, Peter C Hayes, Nicolaas E p Deutz, Roger Williams, Joanna Wardlaw, Rajiv Jalan.   

Abstract

Hyperammonemia is a universal finding after gastrointestinal hemorrhage in cirrhosis. We administered an oral amino acid solution mimicking the hemoglobin molecule to examine neuropsychological changes, brain glutamine levels, and brain magnetization transfer ratio (MTR). Forty-eight metabolically stable patients with cirrhosis and no evidence of "overt" hepatic encephalopathy (HE) were randomized to receive 75 g of amino acid solution or placebo; measurements were performed before and 4 hours after administration. Neuropsychological tests included the Trails B Test, Digit Symbol Substitution Test, memory subtest of the Randt battery, and reaction time. Plasma was collected for ammonia and amino acid measurements, and brain metabolism was studied using proton magnetic resonance (MR) spectroscopy in the first 16 randomized patients. In 7 other patients, MTR was measured. A significant increase in ammonia levels was observed in the amino acid group (amino acid group, 76 +/- 7.3 to 121 +/- 6.4 micromol/L; placebo, 83 +/- 3.3 to 78 +/- 2.9 micromol/L; P <.001). Neuropsychological function improved significantly in the placebo group, but no significant change in neuropsychological function was observed in the amino acid group. Brain glutamate/glutamine (Glx)/creatine (Cr) ratio increased significantly in the amino acid group. MTR decreased significantly from 30 +/-2.9 to 23 +/- 4 (P <.01) after administration of the amino acid solution. In conclusion, an improvement in neuropsychological test results followed placebo, which was not observed in patients administered the amino acid solution. Induced hyperammonemia resulted in an increase in brain Glx/Cr ratio and a decrease in MTR, which may indicate an increase in brain water as the operative mechanism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668989     DOI: 10.1053/jhep.2003.50156

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  30 in total

Review 1.  Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

Authors:  Amit S Seyan; Robin D Hughes; Debbie L Shawcross
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

Review 2.  The brain following transjugular intrahepatic portosystemic shunt: the perspective from neuroimaging.

Authors:  Hui Juan Chen; Gang Zheng; Julian L Wichmann; U Joseph Schoepf; Guang Ming Lu; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2015-09-24       Impact factor: 3.584

3.  Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study.

Authors:  Vijay P B Grover; Mary M E Crossey; Julie A Fitzpatrick; Brian K Saxby; Roberta Shaw; Adam D Waldman; Marsha Y Morgan; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2015-08-08       Impact factor: 3.584

Review 4.  Functional imaging of the brain in patients with liver cirrhosis.

Authors:  Karin Weissenborn; Martin Bokemeyer; Björn Ahl; Daniela Fischer-Wasels; Kathrin Giewekemeyer; Jörg van den Hoff; Herbert Köstler; Georg Berding
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

5.  Role of ammonia and inflammation in minimal hepatic encephalopathy.

Authors:  D L Shawcross; G Wright; S W M Olde Damink; R Jalan
Journal:  Metab Brain Dis       Date:  2007-03       Impact factor: 3.584

6.  Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis.

Authors:  Manuel Romero-Gomez; Maria Jover; Daniel Diaz-Gomez; Laura-Collantes de Teran; Regina Rodrigo; Ines Camacho; Miriam Echevarria; Vicente Felipo; Juan-D Bautista
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

7.  Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.

Authors:  Jatinderpal Singh; Barjesh Chander Sharma; Vinod Puri; Sanjeev Sachdeva; Siddharth Srivastava
Journal:  Metab Brain Dis       Date:  2017-01-09       Impact factor: 3.584

8.  The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial.

Authors:  Nasser Mousa; Ahmed Abdel-Razik; Ashraf Zaher; Magdy Hamed; Gamal Shiha; Narmin Effat; Sherif Elbaz; Rania Elhelaly; Mohamed Hafez; Niveen El-Wakeel; Waleed Eldars
Journal:  Therap Adv Gastroenterol       Date:  2016-05-01       Impact factor: 4.409

9.  Amino acid challenge in patients with cirrhosis and control subjects: ammonia, plasma amino acid and EEG changes.

Authors:  Hanan Al Mardini; Andrew Douglass; Christopher Record
Journal:  Metab Brain Dis       Date:  2006-05-04       Impact factor: 3.584

10.  Voxel-based analyses of magnetization transfer imaging of the brain in hepatic encephalopathy.

Authors:  Falk-R Miese; Hans-Jörg Wittsack; Gerald Kircheis; Arne Holstein; Christian Mathys; Ulrich Mödder; Mathias Cohnen
Journal:  World J Gastroenterol       Date:  2009-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.